Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

TIGIT and PD-1 Immune Checkpoint Pathways Are Associated With Patient Outcome and Anti-Tumor Immunity in Glioblastoma
Itay Raphael, Rajeev Kumar, Lauren McCarl, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

TIGIT-CD226-PVR axis: advancing immune checkpoint blockade for cancer immunotherapy
Eugene Y. Chiang, Ira Mellman
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 4, pp. e004711-e004711
Open Access | Times Cited: 122
Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives
Hao Lin, Chaxian Liu, An-Kang Hu, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 59
Blocking TIGIT/CD155 signalling reverses CD8+ T cell exhaustion and enhances the antitumor activity in cervical cancer
Lu Liu, Aihong Wang, Xiaoli Liu, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 47
Nanomaterials: small particles show huge possibilities for cancer immunotherapy
Ziyin Chen, Ziqi Yue, Kaiqi Yang, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 39
synNotch-programmed iPSC-derived NK cells usurp TIGIT and CD73 activities for glioblastoma therapy
Kyle B. Lupo, Xue Yao, Shambhavi Borde, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 13
Hemin blocks TIGIT/PVR interaction and induces ferroptosis to elicit synergistic effects of cancer immunotherapy
Xiaowen Zhou, Li Yang, Xiangrui Zhang, et al.
Science China Life Sciences (2024) Vol. 67, Iss. 5, pp. 996-1009
Closed Access | Times Cited: 10
Myeloid cells as potential targets for immunotherapy in pediatric gliomas
Stephen C. Frederico, Nikhil Sharma, Corbin Darling, et al.
Frontiers in Pediatrics (2024) Vol. 12
Open Access | Times Cited: 9
Myeloid-derived suppressor cells in hematologic malignancies: two sides of the same coin
Shunjie Yu, Xiaotong Ren, Lijuan Li
Experimental Hematology and Oncology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 28
Immune Checkpoint Molecule TIGIT Regulates Kidney T Cell Functions and Contributes to AKI
Sanjeev Noel, Kyungho Lee, Sepideh Gharaie, et al.
Journal of the American Society of Nephrology (2023) Vol. 34, Iss. 5, pp. 755-771
Closed Access | Times Cited: 18
Lessons learned from phase 3 trials of immunotherapy for glioblastoma: Time for longitudinal sampling?
Ethan Chen, Alexander Ling, David A. Reardon, et al.
Neuro-Oncology (2023) Vol. 26, Iss. 2, pp. 211-225
Open Access | Times Cited: 16
Treatment advances in high-grade gliomas
Xi Chen, Yi Cui, Liqun Zou
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 7
TIGIT: An emerging immune checkpoint target for immunotherapy in autoimmune disease and cancer
Junpeng Zhao, Liming Li, Huiqi Yin, et al.
International Immunopharmacology (2023) Vol. 120, pp. 110358-110358
Closed Access | Times Cited: 13
T Cell Features in Glioblastoma May Guide Therapeutic Strategies to Overcome Microenvironment Immunosuppression
Agnese Losurdo, Antonio Di Muzio, Beatrice Claudia Cianciotti, et al.
Cancers (2024) Vol. 16, Iss. 3, pp. 603-603
Open Access | Times Cited: 5
Novel theranostic agent for PET imaging and targeted radiopharmaceutical therapy of tumour-infiltrating immune cells in glioma
Alexandra Foster, Shubhanchi Nigam, David S. Tatum, et al.
EBioMedicine (2021) Vol. 71, pp. 103571-103571
Open Access | Times Cited: 28
Mutual exclusivity and co-occurrence patterns of immune checkpoints indicate NKG2A relates to anti-PD-1 resistance in gastric cancer
Guanjun Li, Xiaohan Liu, Chunhui Gu, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Neoantigens and their potential applications in tumor immunotherapy (Review)
Xianzhu Fang, Zhiliang Guo, Jinqing Liang, et al.
Oncology Letters (2022) Vol. 23, Iss. 3
Open Access | Times Cited: 17
Novel Immune Checkpoints in Esophageal Cancer: From Biomarkers to Therapeutic Targets
Xueyin Zhou, Ting Ren, Hongyuan Zan, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 17
Immuno-PET Imaging of CD69 Visualizes T-Cell Activation and Predicts Survival Following Immunotherapy in Murine Glioblastoma
Michal Nisnboym, Sarah R. Vincze, Zujian Xiong, et al.
Cancer Research Communications (2023) Vol. 3, Iss. 7, pp. 1173-1188
Open Access | Times Cited: 10
Mannose-modified erythrocyte membrane-encapsulated chitovanic nanoparticles as a DNA vaccine carrier against reticuloendothelial tissue hyperplasia virus
Yang-Yang Feng, Feng Tang, Sheng Li, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 9
Nivolumab Reaches Brain Lesions in Patients with Recurrent Glioblastoma and Induces T-cell Activity and Upregulation of Checkpoint Pathways
Signe K. Skadborg, Simone Maarup, Arianna Draghi, et al.
Cancer Immunology Research (2024) Vol. 12, Iss. 9, pp. 1202-1220
Open Access | Times Cited: 3
Tumor Niches: Perspectives for Targeted Therapies in Glioblastoma
Rashmi Srivastava, Meghana Dodda, Han Zou, et al.
Antioxidants and Redox Signaling (2023) Vol. 39, Iss. 13-15, pp. 904-922
Closed Access | Times Cited: 8
TIGIT axis: novel immune checkpoints in anti-leukemia immunity
Dan Qiu, Xiaxin Liu, Wandi Wang, et al.
Clinical and Experimental Medicine (2022) Vol. 23, Iss. 2, pp. 165-174
Closed Access | Times Cited: 13
Deciphering immune microenvironment and cell evasion mechanisms in human gliomas
Soumaya Rafii, Sarah Kandoussi, Amina Ghouzlani, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 7
Glioma stem cells remodel immunotolerant microenvironment in GBM and are associated with therapeutic advancements
Xifeng Fei, Jie Wu, Haiyan Tian, et al.
Cancer Biomarkers (2024) Vol. 41, Iss. 1, pp. 1-24
Closed Access | Times Cited: 2
Therapeutic approaches to modulate the immune microenvironment in gliomas
Andreas Sarantopoulos, Chibawanye Ene, Elisa Aquilanti
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top